Literature DB >> 11514554

The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells.

D K Panda1, D Miao, V Lefebvre, G N Hendy, D Goltzman.   

Abstract

SOX9 is a transcription factor that is essential for chondrocyte differentiation and cartilage formation. We stably overexpressed SOX9 cDNA in the rat chondrocytic cell line CFK2. Compared with the vector control, a greater proportion of SOX9-transfected cells accumulated in the G0/G1 phase. This was associated with an increase in mRNA and protein expression of p21(cip1), an inhibitor of cyclin-dependent kinase activity. SOX9 enhanced p21(cip1) promoter activity in a luciferase reporter assay. CFK2 cells overexpressing SOX9 became more elongated and adhesive and demonstrated a shift in cytoplasmic F-actin distribution. N-cadherin mRNA levels were elevated in the SOX9-transfected cells, and SOX9 enhanced N-cadherin promoter activity. By electrophoretic mobility shift assay, nuclear extracts of SOX9-transfected CFK2 cells specifically bound an oligonucleotide comprising an N-cadherin promoter region containing a consensus SOX9-binding motif. The transcriptional activity of SOX9 depended upon nuclear localization signals required for SOX9 nuclear entry. Differentiation of transfected CFK2 cells was accelerated as evidenced by more rapid accumulation of alkaline phosphatase activity, increased production of proteoglycans, and increased calcium accumulation, and this was associated with decreased ERK1 expression. These studies demonstrate that SOX9 alters the rate of cell cycle progression of chondrocytes and their differentiation by enhancing or inhibiting the expression of selected genes, including p21(cip1) and ERK1, and that N-cadherin is an additional direct target of this transcriptional regulator.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514554     DOI: 10.1074/jbc.M104231200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation.

Authors:  Bo Liu; Hsiao-Man Ivy Yu; Wei Hsu
Journal:  Dev Biol       Date:  2006-10-21       Impact factor: 3.582

2.  Improved cellular infiltration in electrospun fiber via engineered porosity.

Authors:  Jin Nam; Yan Huang; Sudha Agarwal; John Lannutti
Journal:  Tissue Eng       Date:  2007-09

3.  Towards unraveling ethanol-specific neuro-metabolomics based on ethanol responsive genes in vivo.

Authors:  Raihan K Uddin; Julie A Treadwell; Shiva M Singh
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 4.  Transcriptional control of mesenchymal stem cell differentiation.

Authors:  Jess Frith; Paul Genever
Journal:  Transfus Med Hemother       Date:  2008-05-08       Impact factor: 3.747

5.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

6.  Coculture-driven mesenchymal stem cell-differentiated articular chondrocyte-like cells support neocartilage development.

Authors:  Yueh-Hsun Yang; Anna J Lee; Gilda A Barabino
Journal:  Stem Cells Transl Med       Date:  2012-10-29       Impact factor: 6.940

7.  MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.

Authors:  Jian-Qiang Xu; Wei-Bin Zhang; Rong Wan; Yao-Qi Yang
Journal:  Tumour Biol       Date:  2014-07-03

8.  Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor.

Authors:  Dibyendu Kumar Panda; David Goltzman; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

9.  Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.

Authors:  Thierry Passeron; Julio C Valencia; Takeshi Namiki; Wilfred D Vieira; Hélène Passeron; Yoshinori Miyamura; Vincent J Hearing
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

10.  TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.

Authors:  Dibiyendu Panda; David Goltzman; Harald Jüppner; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.